Affordable Access

Publisher Website

PD-1 and its ligands in T-cell immunity

Authors
Journal
Current Opinion in Immunology
0952-7915
Publisher
Elsevier
Publication Date
Volume
19
Issue
3
Identifiers
DOI: 10.1016/j.coi.2007.04.012

Abstract

The past year has seen significant advances in our understanding of the critical roles of negative immunoregulatory signals delivered by the programmed death 1 (PD-1)–PD-1 ligand (PD-L) pathway in regulating T-cell activation and tolerance. Emerging evidence indicates that PD-Ls play an essential role on dendritic cells (DCs), both directly during DC–T cell interactions and indirectly through signaling into the DC. Recent studies point to a novel role for PD-L1 in maintaining tissue tolerance. Finally, PD-1 has recently been shown to be highly expressed on exhausted T cells during chronic viral infection, and blockade of PD-1 or PD-L1 can revive exhausted T cells, enabling them to proliferate and produce effector cytokines.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

PD-1 and its ligands in T-cell immunity.

on Current Opinion in Immunology June 2007

PD-1 and its ligands in tolerance and immunity.

on Annual Review of Immunology 2008

Superconductivity in a layered Ta4Pd3Te16 with PdT...

on J. of Advances in Biology; 7(1... Jan 29, 2014

PD184352 releases the regular hypoxic reversible D...

on Journal of biochemistry and mo... Nov 30, 2007
More articles like this..